Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 23,154 shares at $73.07 ($1.7M) on 2025-03-03, disclosed to the SEC on 2025-03-03.
Scheduled sale ($1.7M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.02 | 2,869 | $209K | 12.4% |
| 2 | $73.02 | 1,270 | $93K | 5.5% |
| 3 | $72.10 | 3,015 | $217K | 12.8% |
| 4 | $73.07 | 5,915 | $432K | 25.5% |
| 5 | $73.07 | 5,915 | $432K | 25.5% |
| 6 | $73.84 | 2,085 |
| $154K |
| 9.1% |
| 7 | $73.84 | 2,085 | $154K | 9.1% |
| Total | $73.07 avg | 23,154 | $1.7M | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |